Emine Özlem GÜR, Elif SARITAŞ YÜKSEL, Selda HACIYANLI, Cem ÇEKİÇ, Osman Nuri DİLEK, Mehmet HACIYANLI

The predictive value of laboratory factors in evaluating the necessity of surgical treatment in Crohn’s disease

Aim: The primary treatment of Crohn’s disease (CD) is medical but approximately 70% of all patients with CD undergo surgicalintervention throughout their lives. We aimed to determine which parameters can guide decision making before surgical treatmentand to determine the effectiveness of the Glasgow prognostic index (GPI) and prognostic nutritional index (PNI) in predicting thenecessity of surgery.Material and Methods: Patients who underwent surgery or medical treatment for CD were matched for age and sex. Group 1: operatedpatients; Group 2: received medical treatment. Hemogram and biochemistry test results were recorded. Platelet to neutrophil ratio(PNR), Neutrophil to lymphocyte ratio (NLR), and Lymphocyte to monocyte ratio (LMR) were calculated. Patients who had both aserum elevation of CRP (>1.0 mg/dL) and hypoalbuminemia (

PDF

___

1. D. C. Baumgart and W. J. Sandborn, “Crohn’s disease,” Lancet 2012;380:1590-605.
2. Landsend E, Johnson E, Johannessen HO, Carlsen E. Long term outcome after intestinal resection for Crohn’s disease. Scand J Gastroenterol 2006; 41:1204-8.
3. James WT Toh, Peter Stewart, Matthew JFX Rickard, et al. Indications and surgical options for small bowel, large bowel and perianal Crohn’s disease. World J Gastroenterol 2016;22:8892-904.
4. Sheng-Qiang Gao, Li-Dong Huang, Rui-Jie Dai, et al. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn’s disease severity. Int J Clin Exp Pathol 2015;8:14779-85.
5. Hiroshi Takeyama, Tsunekazu Mizushima, Hideki Iijima, et al. Platelet Activation Markers Are Associated with Crohn’s Disease Activity in Patients with Low C-Reactive Protein. Dig Dis Sci 2015;60:3418-23.
6. Acarturk G, Acay A, Demir K, et al. Neutrophil-tolymphocyte ratio in inflammatory bowel disease. As a new predictor of disease severity. Bratisl Lek Listy 2015;116; 213-7.
7. Shibutani M, Maeda K, Nagahara H, et al. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer. Anticancer Res. 2016;36:995-1001.
8. Yamada S, Fujii T, Yabusaki N, et al. Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter. Medicine (Baltimore) 2016;95:3582.
9. Chen H, Hu N, Chang P, et al. Modified Glasgow prognostic score might be a prognostic factor for hepatocellular carcinoma: a meta-analysis. Pan Minerva Med 2016.
10. Dai Y, Fu X, Li T, et al. Long-term impact of prognostic nutritional index in cervical esophageal squamous cell carcinoma patients undergoing definitive radiotherapy. Ann Transl Med 2019;7:175.
11. Luvián-Morales J, González-Trejo S, Carrillo JF, et al. Association of the prognostic nutritional index and overall survival in patients with colorectal cancer: A STROBE compliant retrospective cohort study. Cancer Med 2019.
12. Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85: 1001-5.
13. Bednarz W, Czopnik P, Wojtczak B, Olewiński R, Domosławski P, Spodzieja J. Analysis of results of surgical treatment in Crohn’s disease. Hepatogastroenterology 2008;55:998-1001.
14. Frolkis AD, Dykeman J, Negrón ME, et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and metaanalysis of population-based studies. Gastroenterology 2013; 145:996-1006.
15. Bruining DH and Loftus EV. Current and future diagnostic approaches: from serologies to imaging. Curr Gastroenterol Rep 2007;9:489-96.
16. Naber AH and de Jong DJ. Assessment of disease activity in inflammatory bowel disease; relevance for clinical trials. Neth J Med 2003;61:105-10.
17. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989;298: 82-6.
18. Khan K, Schwarzenberg SJ, Sharp H, et al. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm Bowel Dis 2002;8:325-9.
19. Núñez J, Núñez E, Bodí V, et al. Usefulness of the neutrophil to lymphocyte ratio in predicting longterm mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008;101:747-52.
20. Walsh SR, Cook EJ, Goulder F, et al. Neutrophillymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181-4.
21. Friedman GD, Tekawa I, Grimm RH, et al. The leucocyte count –correlates and relationship to coronary risk factors – the CARDIA study. Int J Epidemiol 1990;19: 889-93.
22. Feng JR, Qiu X, Wang F, et al. Diagnostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-toLymphocyte Ratio in Crohn’s Disease. Gastroenterol Res Pract 2017;2017:3526460.
23. Zhu Y, Xu H, Liu W, et al. Glasgow prognostic score is a practical predictive index for postoperative intraabdominal septic complications after bowel resection in Crohn’s disease patients. Int J Colorectal Dis 2018 ;33:947-53.
24. Zhou W, Cao Q, Qi W, et al. Prognostic Nutritional Index Predicts Short-Term Postoperative Outcomes After Bowel Resection for Crohn’s Disease. Nutr Clin Pract 2017;32:92-7.